LD-2 disclosure · 1st Quarter - Report
HARMONY BIOSCIENCES
Expenses$250Kself-filed spend
Client
- Description
- pharmaceuticals
- Location
- Pennsylvania · United States of America
Registrant
- Description
- pharmaceuticals
- Location
- plymouth meeting, Pennsylvania, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to the development of therapies for rare diseases and sleep disorders; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R. 1805, The Rare Disease Clinical Trials Pandemic Disruption Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act.
LobbyistsCATE MCCANLESS · mr GEOFFREY WERTH
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to Medicare Part D redesign. H.R. 2673, The American Innovation and R&D Competitiveness Act.
LobbyistsCATE MCCANLESS · mr GEOFFREY WERTH
TargetedSENATE · HOUSE OF REPRESENTATIVES